ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors 

2026-08-24

READ MORE >

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

2026-08-07

READ MORE >

NASDAQ - ANIP

$74.17

-1.18 (-1.57%)

Pricing delayed by 20 minutes
Last updated 2026-08-24 16:00:00